Key questions to discuss include: Whether you meet NHS criteria for GLP-1 prescription (type 2 diabetes or obesity with complications) The evidenceor lack thereoffor GLP-1 use specifically in Hashimoto's management Potential interactions between GLP-1 medications and thyroid hormone replacement How GLP-1 therapy might affect your thyroid function monitoring schedule Alternative evidence-based approaches to managing metabolic symptoms in Hashimoto's The costs and practicalities of private prescription if NHS funding is not available Contraception requirements if you are of childbearing potential (GLP-1 medications should be avoided in pregnancy and breastfeeding) Your GP may recommend optimising your current thyroid management first , ensuring your levothyroxine dose is appropriate and that you are not over- or under-replaced
Antimicrobial resistance is a concern, as some peptides impact bacterial populations in unknown ways
Int Wound J 13, 572584.CrossRefGoogle ScholarPubMed Prasad, KN, Chaithra, C, Karthik, Y, et al
Both compounds have distinct safety profiles
At Southern Care Anesthetics, BPC-157 is used to facilitate faster healing, whether for musculoskeletal injuries or other tissues in the body, ensuring a more effective and thorough recovery
Provides strong antioxidant protection